64
Participants
Start Date
April 20, 2021
Primary Completion Date
August 26, 2024
Study Completion Date
August 26, 2024
Muscadine grape extract
Four pills twice daily
Placebo
Four pills twice daily.
Quality of Life Assessment
Ancillary studies
Questionnaires
Ancillary studies
Participant Feedback
Ancillary studies
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
National Center for Advancing Translational Sciences (NCATS)
NIH
National Cancer Institute (NCI)
NIH
Wake Forest University Health Sciences
OTHER